Phase 3, Multinational Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy & Safety of MP-376 in Stable Cystic Fibrosis Patients

Printer-friendly versionPDF version

Name

MPEX Pharmaceuticals

Anticipated Amount

78 585.00

Activity Type

Clinical Trial

Award Type

Contract

Date

June 1, 2010 to July 1, 2012

Award Number

000869-00001

Sponsor Award Number

MPEX-207

Award Contacts

Name

Daines,Cori L

Title

Principal Investigator

Unit

Arizona Respiratory Center

UA@Work is produced by University Communications

Marshall Building, Suite 100. 845 N. Park Ave., Tucson, AZ 85719 (or) 
P.O. Box 210158B, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback University Privacy Statement 

2024 © The Arizona Board of Regents on behalf of the University of Arizona